These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22452744)

  • 1. Impact of a recent lead recall on utilization of implantable cardioverter defibrillators: data from the NCDR ICD Registry™.
    Bhatt P; Curtis J; Wang Y; Lampert R
    J Cardiovasc Electrophysiol; 2012 Aug; 23(8):861-5. PubMed ID: 22452744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of primary prevention implantable cardioverter-defibrillators in a population-based cohort is associated with a significant survival benefit.
    Parkash R; Sapp JL; Basta M; Doucette S; Thompson K; Gardner M; Gray C; Brownell B; Kidwai H; Cox J
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):706-13. PubMed ID: 22685111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparison of ICD implantations in the United States versus Italy.
    Greenberg SM; Epstein AE; Deering T; Goldman DS; Ghidina M; Neason C; Proclemer A
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S143-6. PubMed ID: 17302692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do ICD lead recalls affect physician--or patient--behavior? If not, why not?
    Lewis R; Daubert JP
    J Cardiovasc Electrophysiol; 2012 Aug; 23(8):866-8. PubMed ID: 22812611
    [No Abstract]   [Full Text] [Related]  

  • 5. Characteristics and Outcomes of Pediatric Patients Who Undergo Placement of Implantable Cardioverter Defibrillators: Insights From the National Cardiovascular Data Registry.
    Baskar S; Bao H; Minges KE; Spar DS; Czosek RJ
    Circ Arrhythm Electrophysiol; 2018 Sep; 11(9):e006542. PubMed ID: 30354291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention.
    Chan PS; Nallamothu BK; Spertus JA; Masoudi FA; Bartone C; Kereiakes DJ; Chow T
    Circ Cardiovasc Qual Outcomes; 2009 Jan; 2(1):16-24. PubMed ID: 20031808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of fragmented QRS in primary prevention implantable cardioverter defibrillator recipients with left ventricular dysfunction.
    Forleo GB; Della Rocca DG; Papavasileiou LP; Panattoni G; Sergi D; Duro L; Mahfouz K; Magliano G; Santini L; Romeo F
    J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):779-84. PubMed ID: 21941203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice.
    Kleemann T; Hochadel M; Strauss M; Skarlos A; Seidl K; Zahn R
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):735-40. PubMed ID: 22313314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up.
    Syska P; Przybylski A; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Gepner K; Pytkowski M; Kowalik I; Maczyńska-Mazuruk R; Ruzyłło W; Szwed H
    J Cardiovasc Electrophysiol; 2010 Aug; 21(8):883-9. PubMed ID: 20132378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implant and clinical characteristics for pediatric and congenital heart patients in the national cardiovascular data registry implantable cardioverter defibrillator registry.
    Jordan CP; Freedenberg V; Wang Y; Curtis JP; Gleva MJ; Berul CI
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1092-100. PubMed ID: 25287482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Awareness of indications for device therapy among a broad range of physicians: a survey study.
    Hübinette C; Lund LH; Gadler F; Ståhlberg M
    Europace; 2014 Nov; 16(11):1580-6. PubMed ID: 24451291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary prevention implantable cardioverter-defibrillators in older racial and ethnic minority patients.
    Pokorney SD; Hellkamp AS; Yancy CW; Curtis LH; Hammill SC; Peterson ED; Masoudi FA; Bhatt DL; Al-Khalidi HR; Heidenreich PA; Anstrom KJ; Fonarow GC; Al-Khatib SM
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):145-51. PubMed ID: 25504649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Underutilization of beta-blockers in patients undergoing implantable cardioverter-defibrillator and cardiac resynchronization procedures.
    Hauptman PJ; Swindle JP; Masoudi FA; Burroughs TE
    Circ Cardiovasc Qual Outcomes; 2010 Mar; 3(2):204-11. PubMed ID: 20197509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.
    Gadler F; Valzania C; Linde C
    Europace; 2015 Jan; 17(1):69-77. PubMed ID: 25336667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantation and patient profiles for pacemakers and cardioverter-defibrillators in France (2008-2009).
    Tuppin P; Neumann A; Marijon E; de Peretti C; Weill A; Ricordeau P; Danchin N; Allemand H
    Arch Cardiovasc Dis; 2011 May; 104(5):332-42. PubMed ID: 21693370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with improvement in guideline-based use of ICDs in eligible heart failure patients.
    Mehra MR; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; Liu Y; O'Connor CM; Reynolds D; Walsh MN; Yancy CW; Fonarow GC
    Pacing Clin Electrophysiol; 2012 Feb; 35(2):135-45. PubMed ID: 22145695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [How many leads are needed for an ICD?].
    Schaumann A; Gödde M; Tönnis T
    Herz; 2005 Nov; 30(7):591-5. PubMed ID: 16333583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal Trends Over a Decade of Defibrillator Therapy for Primary Prevention in Community Practice.
    Boveda S; Narayanan K; Jacob S; Providencia R; Algalarrondo V; Bouzeman A; Beganton F; Defaye P; Perier MC; Sadoul N; Piot O; Klug D; Gras D; Fauchier L; Bordachar P; Babuty D; Deharo JC; Leclercq C; Marijon E;
    J Cardiovasc Electrophysiol; 2017 Jun; 28(6):666-673. PubMed ID: 28251724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How many patients fulfil the surface electrocardiogram criteria for subcutaneous implantable cardioverter-defibrillator implantation?
    Randles DA; Hawkins NM; Shaw M; Patwala AY; Pettit SJ; Wright DJ
    Europace; 2014 Jul; 16(7):1015-21. PubMed ID: 24351884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States.
    Charytan DM; Patrick AR; Liu J; Setoguchi S; Herzog CA; Brookhart MA; Winkelmayer WC
    Am J Kidney Dis; 2011 Sep; 58(3):409-17. PubMed ID: 21664735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.